Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Elisabeth Lantéri"'
Autor:
Rémy Peyret, Nicolas Pozin, Stéphane Sockeel, Solène-Florence Kammerer-Jacquet, Julien Adam, Claire Bocciarelli, Yoan Ditchi, Christophe Bontoux, Thomas Depoilly, Loris Guichard, Elisabeth Lanteri, Marie Sockeel, Sophie Prévot
Publikováno v:
PLOS Digital Health, Vol 2, Iss 2, p e0000091 (2023)
Breast cancer is one of the most prevalent cancers worldwide and pathologists are closely involved in establishing a diagnosis. Tools to assist in making a diagnosis are required to manage the increasing workload. In this context, artificial intellig
Externí odkaz:
https://doaj.org/article/0c285490c3ab42778f496d3b93625fcc
Autor:
Marius Ilié, Elisabeth Lantéri, Emmanuel Chamorey, Brice Thamphya, Marame Hamila, Henri Montaudié, Alexandra Picard-Gauci, Sophie Gardrat, Thierry Passeron, Sandra Lassalle, Elodie Long-Mira, Julien Cherfils-Vicini, Eric Gilson, Véronique Hofman, Paul Hofman
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
The outcome of patients with cutaneous melanoma has been strongly modified by recent advances obtained with Immune Checkpoint Inhibitors (ICIs). However, despite this breakthrough, durable response to ICIs is limited to a subset of patients. We inves
Externí odkaz:
https://doaj.org/article/bfd4f825455c4ae1a40fb600d495b127
Autor:
Elisabeth Lantéri, Véronique Hofman, Christophe Bontoux, Samantha Goffinet, Adam Macocco, Élodie Long, Sandra Lassalle, Marius Ilié, Paul Hofman
Publikováno v:
Revue Francophone des Laboratoires. 2022:56-61
Autor:
Sandra Lassalle, Paul Hofman, Olivier Bordone, Simon Heeke, Virginie Lespinet, Virginie Tanga, Michel Poudenx, Elisabeth Lantéri, Véronique Hofman, Marius Ilie, Jacques Boutros, Yvonne Bille, Fabrice Barlesi, C.-H. Marquette, Jonathan Benzaquen, Elodie Long, Christelle Bonnetaud
Publikováno v:
Lung Cancer
Lung Cancer, Elsevier, 2020, 145, pp.58-62. ⟨10.1016/j.lungcan.2020.04.024⟩
Lung Cancer, Elsevier, 2020, 145, pp.58-62. ⟨10.1016/j.lungcan.2020.04.024⟩
Introduction International guidelines recommend BRAF mutational status assessment in treatment-naive advanced non-squamous non-small cell lung carcinoma (NSCLC) patients since the presence of a BRAFV600 mutation enables specific BRAF inhibitor treatm
Autor:
Marius Ilie, Myriam Salah, Sylvie Leroy, Sandra Lassalle, Jonathan Benzaquen, Baharia Mograbi, Véronique Hofman, Virginie Lespinet-Fabre, Olivier Bordone, Maryline Allegra, Elodie Long-Mira, Patrick Brest, Paul Hofman, Elisabeth Lantéri, Charlotte Maniel, Virginie Tanga, Julien Fayada, Simon Heeke, Charles-Hugo Marquette, Jacques Boutros
Publikováno v:
Microbiology Spectrum, Vol 9, Iss 3 (2021)
Microbiology Spectrum
Microbiology Spectrum
Due to increased demand for testing, as well as restricted supply chain resources, testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection continues to face many hurdles. Pooling several samples has been proposed as an alte
Autor:
Géraldine Gonfrier, Arnaud Martel, F. Rocher, Hélène Spittler, Adrien Sanchez, Manon L. Blaise, Elisabeth Lantéri, Thierry Passeron, Angela Puma, Henri Montaudié, Lucia Coco
Publikováno v:
Journal of the European Academy of Dermatology and Venereology
Immune checkpoint inhibitors (ICIs) have dramatically changed the prognosis of advanced melanoma patients, but also exposed them to immune-related adverse events (irAEs).1 Furthermore, with the combination ipilimumab (IPI) plus nivolumab (NIVO) some
Autor:
Emmanuel Chamorey, Paul Hofman, Henri Montaudié, Brice Thamphya, Marius Ilie, Sandra Lassalle, Marame Hamila, Alexandra Picard-Gauci, Thierry Passeron, Sophie Gardrat, Eric Gilson, Véronique Hofman, Julien Cherfils-Vicini, Elodie Long-Mira, Elisabeth Lantéri
Publikováno v:
Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 10, Iss 1 (2021)
OncoImmunology
OncoImmunology, Taylor & Francis, 2021, 10 (1), pp.1901446. ⟨10.1080/2162402X.2021.1901446⟩
article-version (VoR) Version of Record
OncoImmunology, Vol 10, Iss 1 (2021)
OncoImmunology
OncoImmunology, Taylor & Francis, 2021, 10 (1), pp.1901446. ⟨10.1080/2162402X.2021.1901446⟩
The outcome of patients with cutaneous melanoma has been strongly modified by recent advances obtained with Immune Checkpoint Inhibitors (ICIs). However, despite this breakthrough, durable response to ICIs is limited to a subset of patients. We inves
Autor:
Eric Selva, Jonathan Benzaquen, Paul Hofman, Jennifer Griffonnet, Kevin Washetine, Marius Ilie, Christelle Bonnetaud, Maryline Allegra, Charlotte Maniel, Sandra Lassalle, Elodie Long, Virgine Lespinet, Virginie Tanga, Julien Fayada, Marame Hamila, Olivier Bordone, Elisabeth Lantéri, Sylvie Leroy, Zeineb Messaoudi, Lorène Philibert, Charles-Hugo Marquette, Véronique Hofman
Publikováno v:
Biopreservation and biobanking. 18(6)
In only a few months after its inception, the COVID-19 pandemic lead to the death of hundreds of thousands of patients and to the infection of millions of people on most continents, mostly in the United States and in Europe. During this crisis, it wa
Autor:
Sandra, Lassalle, Véronique, Hofman, Simon, Heeke, Jonathan, Benzaquen, Elodie, Long, Michel, Poudenx, Elisabeth, Lantéri, Jacques, Boutros, Virginie, Tanga, Katia, Zahaf, Salomé, Lalvée, Virginie, Lespinet, Olivier, Bordone, Jean-Marc, Félix, Christelle, Bonnetaud, Charles, Marquette, Marius, Ilie, Paul, Hofman
Publikováno v:
Cancers
Background: Assessment of actionable EGFR mutations is mandatory for treatment-naïve advanced or metastatic non-squamous lung carcinoma (NSLC), but the results need to be obtained in less than 10 working days. For rapid EGFR testing, an EGFR-specifi
Autor:
Paul Hofman, Olivier Bordone, Emmanuel Chamorey, Jonathan Benzaquen, Renaud Schiappa, Virginie Lespinet-Fabre, Elisabeth Lanteri, Patrick Brest, Baharia Mograbi, Charlotte Maniel, Virginie Tanga, Maryline Allegra, Myriam Salah, Julien Fayada, Jacques Boutros, Sylvie Leroy, Simon Heeke, Véronique Hofman, Charles-Hugo Marquette, Marius Ilié
Publikováno v:
Frontiers in Medicine, Vol 8 (2022)
Introduction: Aside from the reverse transcription-PCR tests for the diagnosis of the COVID-19 in routine clinical care and population-scale screening, there is an urgent need to increase the number and the efficiency for full viral genome sequencing
Externí odkaz:
https://doaj.org/article/56ae6d0136994ea58da089a78b61379d